期刊文献+

血清视黄醇结合蛋白、脂蛋白A、同型半胱氨酸联合检测对冠心病的诊断价值

Diagnostic value of serum retinol binding protein,lipoprotein A and homocysteine combined detection in coronary heart disease
下载PDF
导出
摘要 目的探讨血清视黄醇结合蛋白(RBP)、脂蛋白A(LpA)、同型半胱氨酸(Hcy)在冠心病患者病程进展中的变化及三者联合检测对冠心病患者的诊断价值。方法纳入2023年1-6月在昆山市第一人民医院心血管内科明确诊断为冠心病的193例患者作为冠心病组,其中急性心肌梗死患者(AMI组)63例,不稳定性心绞痛患者(UAP组)66例,稳定性心绞痛患者(SAP组)64例。另选取同期65例体检健康者为健康对照组(HC组)。检测并比较冠心病组、HC组,以及不同类型冠心病患者血清RBP、LpA、Hcy水平。结果冠心病组血清RBP、LpA、Hcy水平均高于HC组,差异有统计学意义(P<0.01)。冠心病各组RBP、Hcy、LpA水平由高到低依次为AMI组、UAP组、SAP组、HC组,差异均有统计学意义(P<0.05)。冠心病患者RBP、LpA、和Hcy三者联合检测的阳性率高于三者单独检测,并且冠心病各组RBP、LpA和Hcy三项联合检测的阳性率高于三者单独检测,差异均有统计学意义(P<0.05)。结论血清RBP、LpA、Hcy水平与冠心病密切相关,三者联合检测可提高冠心病诊断的检出率。 Objective To investigate the changes of serum retinol binding protein(RBP),lipoprotein A(LpA)and homocysteine(Hcy)in patients with coronary heart disease and the value of their combined detection in the diagnosis of coronary heart disease.Methods A total of 193 patients diagnosed with coronary heart disease in the cardiovascular department of the First People′s Hospital of Kunshan from January to June 2023 were selected as the coronary heart disease group,including 63 patients with acute myocardial infarction(AMI group),66 patients with unstable angina pectoris(UAP group)and 64 patients with stable angina pectoris(SAP group).Another 65 healthy subjects in the same period were selected as healthy control group(HC group).The serum levels of RBP,LpA and Hcy in coronary heart disease group,HC group and patients with different types of coronary heart disease were detected and compared.Results The serum levels of RBP,LpA and Hcy in coronary heart disease group were higher than those in HC group,the differences were statistically significant(P<0.01).The levels of RBP,Hcy and LpA in coronary heart disease groups were AMI group,UAP group,SAP group and HC group from high to low,and the differences were statistically significant(P<0.05).The positive rate of the combined detection of RBP,LpA and Hcy in coronary heart disease patients was higher than that of the single detection,and the positive rate of the combined detection of RBP,LpA and Hcy in coronary heart disease groups was higher than that of the single detection,with statistical significance(P<0.05).Conclusion Serum RBP,LpA and Hcy levels are closely related to coronary heart disease.The combined detection of RBP,LPA and HCY could improve the positive detection rate of coronary heart disease.
作者 段厚全 叶小英 侯颖 DUAN Houquan;YE Xiaoying;HOU Ying(Department of Clinical Laboratory,the First People′s Hospital of Kunshan,Kunshan,Jiangsu 215300,China;Institute of Basic Medicine and Translational Medicine,Xi′an Medical University,Xi′an,Shaanxi 710021,China)
出处 《国际检验医学杂志》 CAS 2023年第20期2494-2497,共4页 International Journal of Laboratory Medicine
基金 陕西省自然科学基金项目(2022JQ-864)。
关键词 冠心病 动脉粥样硬化 视黄醇结合蛋白 同型半胱氨酸 脂蛋白A coronary heart disease atherosclerosis retinol binding protein homocysteine lipoprotein A
  • 相关文献

参考文献10

二级参考文献107

  • 1李娇,李新明,柳亮,王温慧,丛欣鹏,侯士强.血清HMGB1和hs-CRP水平与冠心病严重程度的相关性分析[J].中国动脉硬化杂志,2015,23(2):175-179. 被引量:17
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.

共引文献8780

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部